Looking ahead management team need to deliver over next 10 months not let share price drift below 5 cents as there counting on $10M worth options being converted to shares. Recents appointments to board is great but they need to be paid so cash burn rate more likely to increase as company progresses to trials and hopefully to commercialisation. IHL probably be volatile as we been seeing. DYOR
- Forums
- ASX - By Stock
- Ann: IHL appoints Big-Pharma expert to lead drug development
Looking ahead management team need to deliver over next 10...
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)